{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T03:44:26Z","timestamp":1784087066443,"version":"3.55.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,2,26]],"date-time":"2013-02-26T00:00:00Z","timestamp":1361836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1752-1947-7-54","type":"journal-article","created":{"date-parts":[[2013,2,26]],"date-time":"2013-02-26T11:16:08Z","timestamp":1361877368000},"source":"Crossref","is-referenced-by-count":9,"title":["Drug-induced immune-mediated thrombocytopenia secondary to sunitinib in a patient with metastatic renal cell carcinoma: a case report"],"prefix":"10.1186","volume":"7","author":[{"given":"Zia","family":"Ansari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew K","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,2,26]]},"reference":[{"issue":"7","key":"2451_CR1","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1200\/JCO.2006.06.3602","volume":"25","author":"QM Chow Laura","year":"2007","unstructured":"Chow Laura QM, Eckhardt SG: Sunitinib: from rational design to clinical efficacy. J Clin Oncol. 2007, 25 (7): 884-896. 10.1200\/JCO.2006.06.3602.","journal-title":"J Clin Oncol"},{"key":"2451_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1200\/JCO.2005.02.2194","volume":"24","author":"S Faivre","year":"2006","unstructured":"Faivre S, Delbaldo C, Vera K, Robert C, Lozahic S, Lassau N, Bello C, Deprimo S, Brega N, Massimini G, Armand JP, Scigalla P, Raymond E: Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer. J Clin Oncol. 2006, 24: 25-35. 10.1200\/JCO.2005.02.2194.","journal-title":"J Clin Oncol"},{"key":"2451_CR3","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1056\/NEJMra066469","volume":"357","author":"R Aster","year":"2007","unstructured":"Aster R, Bougie D: Drug-induced immune thrombocytopenia. N Eng J Med. 2007, 357: 580-587. 10.1056\/NEJMra066469.","journal-title":"N Eng J Med"},{"issue":"10","key":"2451_CR4","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1093\/annonc\/mdm454","volume":"18","author":"E Kapiteijn","year":"2007","unstructured":"Kapiteijn E, Brand A, Kroep J, Gelderblom H: Sunitinib induced hypertension, thrombotic microangiopathy and reversible posterior leukencephalopathy syndrome. Ann Oncol. 2007, 18 (10): 1745-1747. 10.1093\/annonc\/mdm454.","journal-title":"Ann Oncol"},{"issue":"4","key":"2451_CR5","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s11523-011-0197-2","volume":"6","author":"R Brown","year":"2011","unstructured":"Brown R: Tyrosine kinase inhibitor-induced hypothyroidism: incidence, etiology, and management. Target Oncol. 2011, 6 (4): 217-226. 10.1007\/s11523-011-0197-2.","journal-title":"Target Oncol"},{"issue":"3","key":"2451_CR6","first-page":"200","volume":"58","author":"A Sella","year":"2012","unstructured":"Sella A, Hercbergs A, Hanovich E, Kovel S: Does sunitinib-induced hypothyroidism play a role in the activity of sunitinib in metastatic renal cell carcinoma?. Int J Exp Clin Chemother. 2012, 58 (3): 200-205.","journal-title":"Int J Exp Clin Chemother"},{"issue":"2","key":"2451_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJMoa065044","volume":"356","author":"RJ Motzer","year":"2007","unstructured":"Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Rixe O, Oudard S, Negrier S, Szczylik C, Kim ST, Chen I, Bycott PW, Baum CM, Figlin RA: Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Eng J Med. 2007, 356 (2): 115-124. 10.1056\/NEJMoa065044.","journal-title":"N Eng J Med"},{"issue":"6","key":"2451_CR8","first-page":"377","volume":"51","author":"A Yoshinaga","year":"2005","unstructured":"Yoshinaga A, Hayashi T, Ohno R, Yoshida S, Ishii N, Terao T, Watanabe T, Yamada T: A case of renal cell carcinoma associated with idiopathic thrombocytopenic purpura. Hinyokika Kiyo. 2005, 51 (6): 377-380.","journal-title":"Hinyokika Kiyo"},{"issue":"3","key":"2451_CR9","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/0090-4295(84)90049-9","volume":"23","author":"I Klimberg","year":"1984","unstructured":"Klimberg I, Drylie D: Renal cell carcinoma and idiopathic thrombocytopenic purpura. Urology. 1984, 23 (3): 293-296. 10.1016\/S0090-4295(84)90049-9.","journal-title":"Urology"},{"issue":"3","key":"2451_CR10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3747\/co.v15i3.233","volume":"15","author":"M Trinkaus","year":"2008","unstructured":"Trinkaus M, Trudeau M, Callum J: Drug-induced immune thrombocytopenic purpura secondary to sunitinib. Curr Oncol. 2008, 15 (3): 152-154.","journal-title":"Curr Oncol"},{"issue":"2","key":"2451_CR11","doi-asserted-by":"publisher","first-page":"80","DOI":"10.5430\/jst.v1n2p80","volume":"1","author":"M Tunio","year":"2011","unstructured":"Tunio M, Ahmad S, Fareed M, AlAsir M: Sunitinib induced immune thrombocytopenia in patient with metastatic renal cell carcinoma. J Solid Tumors. 2011, 1 (2): 80-82.","journal-title":"J Solid Tumors"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1752-1947-7-54\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-7-54.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-7-54","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-7-54.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T13:49:26Z","timestamp":1644414566000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/1752-1947-7-54"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,26]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2451"],"URL":"https:\/\/doi.org\/10.1186\/1752-1947-7-54","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,26]]},"article-number":"54"}}